Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells

Endometrial cancers expressing estrogen and progesterone receptors respond to hormonal therapy. The disappearance of steroid hormone receptor expression is common in patients with recurrent disease, ultimately hampering the clinical utility of hormonal therapy. Here, we demonstrate for the first tim...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chiao-Yun, Chao, Angel, Wang, Tzu-Hao, Lee, Li-Yu, Yang, Lan-Yan, Tsai, Chia-Lung, Wang, Hsin-Shih, Lai, Chyong-Huey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312367/
https://www.ncbi.nlm.nih.gov/pubmed/27527851
http://dx.doi.org/10.18632/oncotarget.11048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312367/
https://www.ncbi.nlm.nih.gov/pubmed/27527851
http://dx.doi.org/10.18632/oncotarget.11048

Ejemplares similares